Uncategorized

We are proud to announce that we recently concluded an exclusive distribution agreement of the TEMGESIC®/ BUPREX® / BUPREXX® (Buprenorphine – Sublingual Tablets & Injections) outside North America. 

With this new addition to our current portfolio, we demonstrate our willingness to keep on extending our activities by entering into a new therapeutic domain: the moderate to severe pain management.  

The strong brand equity of TEMGESIC®/ BUPREX® / BUPREXX®, its key positioning and its particular features are enabling us to reinforce our purpose to guarantee that essential medicines remain accessible to the patients and to the healthcare professionals.

TEMGESIC®/ BUPREX® / BUPREXX® is marketed in complementary countries to our current country scope and we will ensure the continuity of supply in these territories:

• Austria, Belgium, Denmark, France, Germany, Ireland, Italy, Luxembourg, The Netherlands, Spain, Sweden;

• Australia, Hong Kong, Malaysia, New Zealand, Singapore, Taiwan;

• As well as in United Kingdom, Norway, Switzerland & South Africa.  

We are looking to the future with enthusiasm, comforted by the quality of our team, of our approach and of our diversified portfolio of therapeutic solutions.

Want to know more?  Please contact us to info@3.64.170.253

After announcing our warehouse expansion in January, we are proud to inform you that we are increasing our storage capacity thanks to the acquisition of  a 1000m² warehouse.

This new facility named Eumedica Scailmont located close to our main site Eumedica Nauwelette is a step forward to meet the growing demand of storage from our current and new customers. Indeed, storing there any non-GDP material will enable us to free up some space in our GDP areas for pharmaceutical products in our main warehouse (-40°C, -20°C, 2-8°C, 15-25°C).

This expansion will definitely contribute to keep a high customers’ satisfaction, and to fulfil our mission: “Ensuring Medical Care Continuity “

It sounds like yesterday we announced the extension of our warehouse. Times flies and major milestones have been accomplished since January. Today, we’re happy to share with you some new views of the work progress.

This new 3000sqm warehouse is the logical continuation of former extensions and falls within our mission to ensure medical care continuity. With more GDP storage spaces and GMP rooms, it is designed to expand our activities and meet the constant growing demand:

• GDP storage for pharmaceutical products at 15-25°C; 2-8°C; -20°C and -40°C
• GMP rooms for labelling and packaging at 15-25°C; 2-8°C; -20°C

Today, we are celebrating the 6^th edition of the International Day of Women and Girls in Science. This annual international day has been established to recognize the critical role women and girls play in science and technology. It is an opportunity to promote full and equal access to and participation in science for women and girls.On this occasion, we want to introduce you to our Medical Science Liaison Germany, Kristina Grimm.

Kristina, why have you chosen to step into the scientific world ?

I’ve always seen science as an adventure. You explore, investigate and develop new components. You are always at the forefront to learn and search something new. It’s all about facts. You can prove what you see. For these reasons I started my biologist studies at the University of Münster and Köln and I worked in a lab.

How working as a MSL make sense to you?

After obtaining my PhD and working in a lab in the US, I started my professional career as Account Manager for companies specialised in pharmaceutical products for rare diseases. While I enjoyed these experiences, I felt I missed the scientific part of it.

At Eumedica, as MSL for the German market, I help to ensure that our products are utilized effectively and serve as scientific support for the medical community and internal colleague. Moreover, I enjoy developing relationships with specialists who are involved in the infectiology research such as microbiologists and epidemiologists.

Being the link between both sides is very exciting and inspiring every day as, at my own scale, I contribute to making sure patients are treated in the most effective way.  

How is Eumedica different from other places you’ve worked at?

From the beginning, I felt that Eumedica believes in its people, and it doesn’t matter whether you’re a woman or a man. From my experience, I know it’s not always the case unfortunately. As from my job interviews at Eumedica I immediately thought that I was considered as an equal and that our discussions were more exchanges of experiences between two colleagues.

Besides, at Eumedica, while most of the activity is in Belgium, working abroad is not an issue. Indeed,  everything is put in place so it doesn’t matter where you work, you’re a strong member of the family. 

Eumedica is thrilled to have reached the oustanding milestone of having more than 2000 followers on LinkedIn. We want to warmly thank everyone who is engaging with our page and are looking forward to sharing more exciting news with you.

You’re not a follower yet? Here are a few reasons why you should join our community on LinkedIn:

• Be the first to hear about our new services and business opportunities;
• Find out about all congresses and other events we attend;
• Check out our job opportunities and get the chance to join our growing company.

Hopefully, we’ll count you soon as one of our followers on LinkedIn.

In order to meet constant growing demand, we are proud to announce the extension of our warehouse floor space from 7000sqm to 10000sqm. This exciting development is set to provide our customers with more GDP storage spaces and GMP rooms (labelling and packaging) for cold and ambient pharmaceutical products.

This new 3000sqm warehouse is designed to expand our activities through the following areas:

• GDP storage for pharmaceutical products at 15-25°C; 2-8°C; -20°C and -40°C
• GMP rooms for labelling and packaging at 15-25°C; 2-8°C; -20°C

“This new infrastructure is the logical continuation of former extensions and falls within our mission to ensure medical care continuity. Everyone at Eumedica is very excited by this expansion and recognise it will extend customers’ satisfaction with the same standards of services, flexibility and know-how that we have been providing for 35 years.” Virginie De Coster, Managing Director.

We are committed  to our ethos of ensuring medical care continuity and bringing vital medicines to care-givers and patients throughout the world. To this end, we have recently been approved as an AEO (Authorised Economic Operator).

What is AEO status?

The AEO is granted to companies who are involved in customs operations and international trade, and meet a range of strict criteria related to supply chain security. It shows that our business’ role in the global supply chain is secure and reliable. In other words, it seeks to create a frictionless relationship between us and customs authorities around the world, based on mutual confidence and integrity.

What are the advantages?

In the first instance, we have been awarded the Authorised Economic Operator Customs Simplification (AEOC) status. This certificate, not only recognises our reliability and stringent processes, but also allows us to benefit from:

• Easier admittance to customs simplifications     
• Priority treatment if selected for control
• Possibility to request a specific place for customs controls
• Fewer physical and document-based controls related to other customs legislation

The AEOC status is vital for our company to allow us to meet the global demands of our customers; expediting procedures to get our products to where they are needed, to help patients around the world.

Should you need more information about our services, feel free to complete the contact form.

With the Brexit transition period drawing to an end on 31st December 2020, we shall enter the new year with many rules changing on the import of goods from the EU into the UK. We have been working tirelessly to adapt to this new environment and ever striving to bridge this gap between Europe and the UK.

We are very proud to announce the launch of a new Eumedica entity: Eumedica Pharma Ltd. This new entity will enable us to overcome many of the challenges Brexit has presented all companies who rely on a European partnership, like us.

The transition period

Back in January 2020 saw the beginning of the transition period to the end of this year. We formed a new alliance with a UK distributor to store and ship medicines throughout the UK hospital network to maintain our commitment to vital medical care continuity. This guaranteed no disruption to the supply of our medicines for our customers and patients throughout this uncertain and trying period.

Our customers and the new entity

Our main priority is to limit the impact on our customers as much as possible. From the 1st January 2021 the only aspect that will change is our contact details; the team who have always managed your orders and the distributors who have delivered our medicines to you, will remain the same. Furthermore, our sales and promotion team, led by Véronique Van Ranst, Head of the UK Markets, continue to support you and will be on hand to deal with any queries you may have.

New contact details

From 1st January 2021 please use the following contact details if you contact us from the UK:

Eumedica Pharma Ltd
8 Northumberland Avenue, WC2N 5BY, London, United Kingdom
Phone +44 (0) 20 8444 3377 | Fax +44 (0) 20 8444 6866
Email : e-orders@eumedica.co.uk | Website : http://www.eumedica.co.uk
VAT : GB350 1686 15

The creation of Eumedica Pharma Ltd. is another step forward to allow us to continue providing a first-class service to our customers and ensuring medical care continuity in the UK.

For more information, please contact us now.

In the current climate of the Coronavirus pandemic, Eumedica is dedicated to carry out its mission: “Ensuring Medical Care Continuity”. This is only possible through the continued hard-work and dedication of our colleagues. This is why the health and safety of our colleagues is of the utmost importance, now more than ever. Where feasible, we have implemented homeworking. Some of what we do needs to be done on site; we therefore constantly monitor the situation and are taking appropriate measures to ensure the safety of our people.

What Eumedica is doing in-house

Providing a safe working environment for all of our colleagues is our top-priority. To achieve this, we have reduced the number of people on site to the absolute minimum required and have implemented home-based working for all other colleagues. We are raising awareness internally around increased hygiene measures, strengthening our disinfection plan, cancelling all non-essential business travel, and keeping a minimum of 1.5m distance. With regards to our clients, we maintain contact using video-conferencing, telephone and email. We are always available to answer our clients queries!

In a matter of just a few days, we have all embraced the new digital tools to keep our teams working for you!

Medicines distribution, a vital service

As a key distributor of medicines, we are a vital service for the population across many countries. Consequently, it is crucial to continue our work so patients can receive their treatment on time. All our teams work tirelessly to maintain the supply of medicines for these patients. Therefore, we guarantee to remain operational and continue all our GDP and GMP activities and to manage all orders and requests. Meanwhile, we will be dynamic to any changes made by the authorities on a local, continental or worldwide scale, and act accordingly.

In these challenging times, we would like to thank all of our colleagues who are working hard to deliver vital medicines to patients. While we make sure the conditions are as safe as possible, we are proud to see such flexibility and cohesion to fulfil our mission: “Ensuring Medical Care Continuity”!